Carregant...
Microdialysis Measurement of Intratumoral Temozolomide Concentration after Cediranib, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, in a U87 Glioma Model
BACKGROUND: Combining anti-angiogenesis agents with cytotoxic agents for the treatment of malignant gliomas, may affect the cytotoxic drug distribution by normalizing the blood brain-barrier (BBB). This study examines the intratumoral concentration of temozolomide (TMZ) in the presence and absence o...
Guardat en:
| Publicat a: | Cancer Chemother Pharmacol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596243/ https://ncbi.nlm.nih.gov/pubmed/23649683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2172-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|